| Ascension PyroCarbon Radial Head Study (NCT02405234) | Smith & Nephew, Inc. | 2009-01-01 |
| A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis. (NCT00838058) | Pfizer | 2009-01-01 |
| Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica (NCT00847236) | Lahey Clinic | 2009-01-01 |
| Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine (NCT02809833) | Hoffmann-La Roche | 2009-01-01 |
| Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA (NCT00858780) | Pfizer | 2009-01-01 |
| Italian Registry of Arthritis on Biologic Therapy (NCT01543594) | Gruppo Italiano Studio Early Arthritis | 2009-01-01 |
| A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis (NCT00848120) | Hoffmann-La Roche | 2008-12-31 |
| Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis (NCT00818064) | Novo Nordisk A/S | 2008-12-01 |
| Marine Oils and Arthritis (NCT00805116) | National Institute of Nutrition and Seafood Research, Norway | 2008-12-01 |
| A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects (NCT01011959) | Regeneron Pharmaceuticals | 2008-12-01 |
| Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan (NCT00888576) | Pfizer | 2008-12-01 |
| A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography (NCT00767325) | Bristol-Myers Squibb | 2008-12-01 |
| n-3 and n-6 Fatty Acids in Rheumatoid Arthritis (NCT01179971) | Charite University, Berlin, Germany | 2008-12-01 |
| A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs (NCT00810277) | Hoffmann-La Roche | 2008-11-30 |
| A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood (NCT00781469) | Imperial College London | 2008-11-01 |
| A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis (NCT00783536) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy (NCT00948610) | University of California, Los Angeles | 2008-11-01 |
| Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia (NCT00751387) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA) (NCT00796705) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| The Chinese University of Hong Kong Early Arthritis Study (NCT00901550) | Chinese University of Hong Kong | 2008-11-01 |
| Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) (NCT00791999) | Otsuka Pharmaceutical Co., Ltd. | 2008-11-01 |
| Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) (NCT00791921) | Otsuka Pharmaceutical Co., Ltd. | 2008-11-01 |
| A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis. (NCT00773461) | Hoffmann-La Roche | 2008-10-31 |
| Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis (NCT00771030) | Amgen | 2008-10-27 |
| A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis (NCT00771420) | MedImmune Ltd | 2008-10-01 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis (NCT00779220) | Chugai Pharmaceutical | 2008-10-01 |
| A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy (NCT00785928) | Eli Lilly and Company | 2008-10-01 |
| Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients (NCT00768053) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis (NCT00771329) | Biogen | 2008-10-01 |
| Living Well With Rheumatoid Arthritis (NCT00869349) | Brigham and Women's Hospital | 2008-09-01 |
| A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521) (NCT00724672) | Merck Sharp & Dohme LLC | 2008-09-01 |
| Ultrasonography as a Biomarker in Early Rheumatoid Arthritis (NCT00781989) | Imperial College London | 2008-09-01 |
| Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan (NCT00747578) | Taichung Veterans General Hospital | 2008-09-01 |
| Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) (NCT00753454) | UCB Pharma | 2008-09-01 |
| Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA) (NCT00717808) | Imperial College London | 2008-09-01 |
| An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy. (NCT00750880) | Hoffmann-La Roche | 2008-09-01 |
| Bone Resorption, Osteoclastogenesis and Adalimumab (NCT00814866) | Université de Sherbrooke | 2008-09-01 |
| A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088) (NCT00746512) | Merck Sharp & Dohme LLC | 2008-09-01 |
| Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study (NCT00780793) | Assistance Publique - Hôpitaux de Paris | 2008-09-01 |
| Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs (NCT01083693) | Abbott | 2008-09-01 |
| A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis. (NCT00754559) | Hoffmann-La Roche | 2008-08-01 |
| Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar® (NCT00828997) | Region Skane | 2008-08-01 |
| Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies (NCT00805467) | AstraZeneca | 2008-08-01 |
| A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis (NCT00713544) | AstraZeneca | 2008-07-01 |
| RESTART C0168Z05 Rheumatoid Arthritis Study (NCT00714493) | Centocor Ortho Biotech Services, L.L.C. | 2008-07-01 |
| Pre-operative Rehabilitation Exercise Program for Total Knee Arthroplasty (NCT00493142) | University of Alberta | 2008-07-01 |
| A Study of ARRY-371797 in Patients With Rheumatoid Arthritis (NCT00729209) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-07-01 |
| A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis (NCT00718588) | Genentech, Inc. | 2008-07-01 |
| Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis (NCT00712114) | Harbor Therapeutics | 2008-07-01 |
| Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers (NCT00782600) | Pfizer | 2008-07-01 |
| Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis (NCT01055899) | Regeneron Pharmaceuticals | 2008-07-01 |
| Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (NCT00717236) | UCB Pharma | 2008-07-01 |
| Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers (NCT00711074) | AstraZeneca | 2008-06-01 |
| Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis (NCT01076959) | Abbott | 2008-06-01 |
| Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) (NCT00147966) | University of California, San Diego | 2008-06-01 |
| Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA) (NCT00786227) | Stanford University | 2008-06-01 |
| Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose) (NCT00794118) | Pfizer | 2008-06-01 |
| Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056 (NCT00700986) | AstraZeneca | 2008-06-01 |
| Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects (NCT02151409) | Novo Nordisk A/S | 2008-06-01 |
| Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (NCT00674362) | UCB Pharma | 2008-06-01 |
| LPS Flex Porous Femoral Components (NCT01462240) | Zimmer Biomet | 2008-05-20 |
| Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) (NCT00665626) | Rigel Pharmaceuticals | 2008-05-01 |
| Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis (NCT00695188) | Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation | 2008-05-01 |
| Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (NCT00665925) | Rigel Pharmaceuticals | 2008-05-01 |
| A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA) (NCT00771251) | Janssen Pharmaceutical K.K. | 2008-05-01 |
| Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis (NCT00667758) | Betanien Hospital | 2008-05-01 |
| A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT00727987) | Janssen Pharmaceutical K.K. | 2008-05-01 |
| Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects (NCT00721994) | Corin | 2008-05-01 |
| A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy (NCT00673920) | Genentech, Inc. | 2008-04-24 |
| Cormet Post-PMA Study: New Enrollment (NCT00722007) | Corin | 2008-04-24 |
| Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use (NCT01083160) | Abbott | 2008-04-01 |
| Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment (NCT00902005) | Revmatismesykehuset AS | 2008-04-01 |
| A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) (NCT00661284) | Chugai Pharmaceutical | 2008-04-01 |
| Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan (NCT00661661) | Pfizer | 2008-04-01 |
| Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis (NCT00641225) | Pfizer | 2008-03-31 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate (NCT01000610) | Hoffmann-La Roche | 2008-03-17 |
| Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III) (NCT00664521) | Merck KGaA, Darmstadt, Germany | 2008-03-01 |
| Effects of Probiotics on Rheumatoid Arthritis Patients (NCT00664820) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2008-03-01 |
| Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis (NCT00650078) | Amgen | 2008-03-01 |
| A Study of ARRY-438162 in Patients With Rheumatoid Arthritis (NCT00650767) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-03-01 |
| Long Term Experience With Abatacept in Routine Clinical Practice (NCT02109666) | Bristol-Myers Squibb | 2008-03-01 |
| Fitmore Hip Stem PMCF Study: A Multi-centre, Non-comparative, Prospective Post-market Clinical Follow-up Study. (NCT03411044) | Zimmer Biomet | 2008-02-08 |
| Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) (NCT01017367) | Bristol-Myers Squibb | 2008-02-01 |
| Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT00639834) | Bristol-Myers Squibb | 2008-02-01 |
| Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients (NCT00556894) | Can-Fite BioPharma | 2008-02-01 |
| Efficacy of the CLP® Hip - Retrospective (NCT00764842) | Encore Medical, L.P. | 2008-01-01 |
| Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study (NCT00793403) | Pfizer | 2008-01-01 |
| A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) (NCT00741104) | Merck Sharp & Dohme LLC | 2008-01-01 |
| 3DKnee™ System vs. the MJS Knee System (NCT00764803) | Encore Medical, L.P. | 2008-01-01 |
| Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care (NCT01163916) | Abbott | 2008-01-01 |
| Effect of Healing on Rheumatoid Arthritis (NCT00967395) | Henning Bliddal | 2008-01-01 |
| A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA) (NCT01362153) | Centocor, Inc. | 2007-12-26 |
| Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response (NCT03414502) | University of Nebraska | 2007-12-10 |
| Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing (NCT00647270) | Abbott | 2007-12-01 |
| PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity (NCT00576706) | Korea Otsuka Pharmaceutical Co., Ltd. | 2007-12-01 |
| A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis. (NCT00580229) | University of South Florida | 2007-12-01 |
| A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis (NCT01231321) | Abbott | 2007-12-01 |
| Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis (NCT00963703) | University of Manitoba | 2007-12-01 |
| Dosing Flexibility Study in Patients With Rheumatoid Arthritis (NCT00580840) | UCB Pharma | 2007-12-01 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. (NCT00576433) | Hoffmann-La Roche | 2007-12-01 |